Publication | Closed Access
Denosumab versus alendronate in long-term glucocorticoid users: A 12-month randomized controlled trial
27
Citations
24
References
2021
Year
Bone DiseaseRheumatology12-Month RandomizedPharmacologyOsteoarthritisLong-term Glucocorticoid UsersDenosumab Versus AlendronateGlucocorticoidMedicineOsteoporosisRheumatoid Arthritis
| Year | Citations | |
|---|---|---|
Page 1
Page 1